An FDA approval is always considered a win for the manufacturer, and often it is also seen as a win for the particular clinical space that the product is intended for. But once in a while, the coveted U.S. regulatory approval can be viewed as a win on an even larger scale. Jim Mazzo, chairman/CEO of AcuFocus (Irvine, California), told Medical Device Daily that this week's FDA approval of his company's Kamra inlay is an example of one of those occasions. Read More
